A response to 'Nanotechnology and the need for risk governance', O. Renn & M.C. Roco, 2006. J. Nanoparticle Research 8(2): 153-191

Journal of Nanoparticle Research

Volumn 9, Issue 6, 2007, Pages 1217-1220

  Bijker, W E ^a   De Beaufort, I D ^b   Van Den Berg, A ^c   Borm, P J A ^d,e   Oyen, W J G ^f   Robillard, G T ^g   Van Dijk, H F G ^h  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

^d ZUYD UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g Biomade Technology Foundation   (Netherlands)

^h Health Council of the Netherlands   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NANOMATERIAL; NANOPARTICLE; RUBBER;

ARTICLE; COTTON; DEVELOPING COUNTRY; GENOMICS; NANOTECHNOLOGY; NETHERLANDS; PRIORITY JOURNAL;

EID: 34748841481     PISSN: 13880764     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11051-007-9261-3     Document Type: Article

References (7)

1. Borm P, Klaessig FC, Landry TD, Moudgil B, Pauluhn J, Thomas K, Trottier R, Wood S (2006) Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. Toxicol Sci 90(1):23-32
2. Health Council of the Netherlands (2006) Health significance of nanotechnologies. The Hague: Health Council of the Netherlands; publication no. 2006/06E; www.healthcouncil.nl
3. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622-627
4. Renn O (2005) White paper on risk governance; towards an integrative approach. White paper no. 1. Geneva: International Risk Governance Council; www.irgc.org
5. Renn O, Roco MC (2006a) Nanotechnology and the need for risk governance. J Nanopart Res 8(2):153-191
6. Renn O, Roco MC (2006b) White paper on nanotechnology risk governance. White paper no. 2. Geneva: International Risk Governance Council; www.irgc.org
7. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2005) Opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. Brussels: European Commission, Health & Consumer Protection Directorate-General, Directorate C-Public Health and Risk Assessment